# Sublingual Semaglutide Drops: What the Evidence Shows

By Ruth Calder, Enforcement Editor (https://glpwatchdog.org/authors/ruth-calder) | Published: 2026-09-27 | Updated: 2026-11-02

Canonical page: https://glpwatchdog.org/research/sublingual-semaglutide-drops-evidence

> No FDA-approved sublingual semaglutide exists and no human absorption study is published. The approved tablet absorbs about 1% to 2% of its dose even with an enhancer. Evidence and seller prices.

No one has shown that sublingual semaglutide drops work in people. There is no FDA-approved sublingual semaglutide, and we found no published human study measuring how much semaglutide from drops, lozenges or under-the-tongue tablets reaches the blood. The approved semaglutide pill shows [how hard needle-free delivery is](https://glpwatchdog.org/research/peptides-without-needles): with a purpose-built absorption enhancer and strict dosing rules, its label puts absorption at about 1% to 2% of the dose.

> **About this article.** The label figures come from the FDA-approved labels on DailyMed. The evidence section covers every relevant PubMed record we found in September 2026, and the price table lists sellers we track whose own pricing names a drop, sublingual or lozenge form of semaglutide.

## What sublingual semaglutide is

“Sublingual semaglutide” is a compounded preparation: a pharmacy mixes semaglutide into drops, a lozenge (sometimes called a troche) or a tablet meant to dissolve under the tongue. Every semaglutide label on DailyMed is an injection or a tablet you swallow; none is a sublingual, buccal or liquid form.[1][2] FDA says a compounded drug carries no FDA approval and gets no agency check of its safety, effectiveness or quality before sale.[3]

The pitch is that the thin tissue under the tongue lets a drug skip the stomach. Semaglutide is a large peptide, about 4,114 daltons,[6] the same size problem that rules out [GLP-1 patches](https://glpwatchdog.org/research/do-glp1-patches-work). See our [glossary entry on sublingual troches](https://glpwatchdog.org/glossary/sublingual-troche) for the dosage form itself.

## The approved oral semaglutide, and what it needs to work

Two approved tablets exist. The Wegovy tablet is approved for weight reduction in adults who have obesity, or who are overweight and also have a condition linked to their weight.[1] Rybelsus is approved for adults with type 2 diabetes, and its current label also covers Ozempic tablets.[2] Both are swallowed, not dissolved in the mouth, and both contain SNAC (salcaprozate sodium), which the labels describe as an absorption enhancer.[1][2]

Even with SNAC, absorption is fragile enough that the labels set strict rules:

- Take it first thing in the morning, before any food.[1]
- Use plain water only, 4 ounces at most.[1][2]
- Then hold off on food, drinks and other pills for half an hour or longer.[1]

*How much semaglutide reaches the blood, by form (FDA labels)*

| Form | Absolute bioavailability | Maintenance dose |
| --- | --- | --- |
| Wegovy injection | 89% | 2.4 mg once a week |
| Wegovy tablet (with SNAC) | About 1% to 2% | 25 mg once a day |
| Rybelsus tablet (with SNAC) | About 0.4% to 1% | 3, 7 or 14 mg tablets, once a day |
| Compounded sublingual drops or lozenges | No human measurement published | Set by each seller |

Sources: the Wegovy and Rybelsus labels.[1][2] Our comparison of [the Wegovy pill and the shot](https://glpwatchdog.org/research/is-the-pill-as-good-as-the-shot) covers how the two approved forms compare in trials.

## What has been tested for drops and other mouth forms

We searched PubMed in September 2026 for sublingual and buccal semaglutide and for sublingual or buccal GLP-1 drugs in general, and read every abstract. None reports a human study measuring blood levels, weight or blood sugar after sublingual or buccal semaglutide. The published work is in animals, plus one human study of whether people would wear a cheek patch:

*Published studies of semaglutide absorbed through the mouth*

| Study | Subjects | What was tested | Result |
| --- | --- | --- | --- |
| Liu et al., 2026[4] | Rats | One dose of semaglutide in a suspension under the tongue, against a swallowed tablet and an injection | Relative bioavailability 0.29% to 0.34% under the tongue, against 0.06% for the swallowed tablet at the same dose |
| Sagar et al., 2026[5] | 40 minipigs | A dissolving film under the tongue, made with a permeation enhancer (SDS or SNAC), three times a week for 8 weeks | 24.9% less weight gain than placebo |
| Klein Cerrejon et al., 2025[6] | Dogs | A suction patch stuck inside the cheek for 30 minutes | Bioavailability 9.6 times the commercial tablet |
| Luo et al., 2023[7] | Dogs, then 40 healthy people | The first version of that suction patch | Dogs matched the approved tablet’s exposure; the human study tested whether people accepted wearing the patch |
| Wu et al., 2024[8] | Mice | Semaglutide mixed with new carrier peptides under the tongue | Blood sugar effect comparable to an injection |

The study closest to a commercial drop is the rat study, whose authors work in research and development at a compounding-supply company. It gave the sublingual group a dose of 1 mg/kg, about 90 times the injected dose of 0.011 mg/kg, and still reached a relative bioavailability of about a third of one percent.[4] The better animal results all came from engineered systems, such as enhancer-loaded films, suction patches and new carrier peptides, that are not what a dropper bottle contains.

In people, one registered trial run by a telehealth company, NCT07092605, includes a weekly sublingual GLP-1 arm. It lists its status as enrolling by invitation and has posted no results.[10] A 2026 survey of compounded GLP-1 products sold online found that 82% of the single-ingredient semaglutide and tirzepatide products it identified were sublingual, and concluded that whether these forms “offer advantages over innovator oral tablets has not been determined.”[9]

## Why a milligram in a dropper is not a milligram in a pen

The approved labels show why. The Wegovy tablet’s maintenance dose is 25 mg every day, or 175 mg a week, to do the work of a 2.4 mg weekly injection.[1] That is about 73 times as much drug by mouth. The Rybelsus label also says its own tablets and Ozempic tablets “are not substitutable on a mg-to-mg basis,” even though both are approved, swallowed and made with the same enhancer.[2]

If two approved tablets cannot be swapped milligram for milligram, a drop with a different vehicle, a different route and no published absorption data cannot be assumed to match either. The dose on a compounded bottle tells you how much semaglutide went in. It does not tell you how much reaches your blood. For more on what goes into these preparations, see [what is in a compounded GLP-1](https://glpwatchdog.org/research/what-is-in-a-compounded-glp1-vial).

## What sellers charge for semaglutide drops and lozenges

Of the sellers we track, 29 list a drop, sublingual or lozenge form of compounded semaglutide with its own price. Starting prices run from $99 to $400 a month. Prices were last checked on each seller’s site between September 2026 and November 2026; click a name for the full review.

*Compounded semaglutide in drop, sublingual and lozenge forms: starting prices*

| Seller | Form, as the seller describes it | Starting price | Checked |
| --- | --- | --- | --- |
| [AlyveRx](https://glpwatchdog.org/reviews/alyverx) | Sublingual drops | $203 a month | October 2026 |
| [BMI Doctors](https://glpwatchdog.org/reviews/bmi-doctors) | Sublingual drops | $279 a month | November 2026 |
| [Direct Meds](https://glpwatchdog.org/reviews/direct-meds) | Sublingual | $249 a month | October 2026 |
| [DoctorAdam](https://glpwatchdog.org/reviews/doctoradam) | Sublingual drops | $129 a month | October 2026 |
| [ElitePhysiqMD](https://glpwatchdog.org/reviews/elitephysiqmd) | Sublingual | $265 a month | October 2026 |
| [EllieMD](https://glpwatchdog.org/reviews/elliemd) | Oral drops | $299 a month, paid several months up front | October 2026 |
| [Found Youth](https://glpwatchdog.org/reviews/found-youth) | Sublingual drops | $179 a month | October 2026 |
| [FWD Care](https://glpwatchdog.org/reviews/fwd-care) | Sublingual | $149.99 a month | November 2026 |
| [Gide Health](https://glpwatchdog.org/reviews/gide-health) | Oral drops | $149 a month | October 2026 |
| [HealthHub](https://glpwatchdog.org/reviews/healthhub) | Sublingual | $149 a month | October 2026 |
| [Layla](https://glpwatchdog.org/reviews/layla) | Oral drops | $237 a month ($187 first month) | October 2026 |
| [Lumora](https://glpwatchdog.org/reviews/lumora) | Sublingual drops | $295 a month | October 2026 |
| [MadeMed](https://glpwatchdog.org/reviews/mademed) | Sublingual tablet | $219 a month, paid several months up front | October 2026 |
| [Mankind Health](https://glpwatchdog.org/reviews/mankind-health) | Sublingual | $269.10 a month | November 2026 |
| [Mojoon](https://glpwatchdog.org/reviews/mojoon) | Sublingual drops | $400 a month | October 2026 |
| [NexLife](https://glpwatchdog.org/reviews/nexlife) | Sublingual tablet | $199 a month | October 2026 |
| [Nova](https://glpwatchdog.org/reviews/nova-trynova) | Sublingual tablet | $127 a month | October 2026 |
| [Onyx Weight Loss](https://glpwatchdog.org/reviews/onyx-weight-loss) | Sublingual | $399 a month | October 2026 |
| [RenewMD](https://glpwatchdog.org/reviews/renewmd) | Sublingual | $279 a month | November 2026 |
| [Rewinding RX](https://glpwatchdog.org/reviews/rewinding-rx) | Sublingual drops | $139 a month | October 2026 |
| [Riovie](https://glpwatchdog.org/reviews/riovie) | Sublingual tablet | $195 a month, paid several months up front; up to $209 at higher doses | November 2026 |
| [ShedRx](https://glpwatchdog.org/reviews/shedrx) | Lozenge or troche | $199 a month | November 2026 |
| [ShedRx](https://glpwatchdog.org/reviews/shedrx) | Oral drops | $229 a month | November 2026 |
| [SkyRx](https://glpwatchdog.org/reviews/skyrx) | Oral drops | $199 a month, paid several months up front | October 2026 |
| [Strut Health](https://glpwatchdog.org/reviews/strut-health) | Lozenge or troche | $99 a month | October 2026 |
| [TelePeptide](https://glpwatchdog.org/reviews/telepeptide) | Sublingual tablet | $229 a month | October 2026 |
| [Tomorrow](https://glpwatchdog.org/reviews/tomorrow) | Sublingual drops | $199 a month | October 2026 |
| [Try Ageless](https://glpwatchdog.org/reviews/try-ageless) | Lozenge or troche | $249 a month | October 2026 |
| [Try Ageless](https://glpwatchdog.org/reviews/try-ageless) | Sublingual drops | $199 a month | October 2026 |
| [VigorMeds](https://glpwatchdog.org/reviews/vigormeds) | Sublingual | $139 a month | October 2026 |
| [Wisp](https://glpwatchdog.org/reviews/wisp) | Sublingual drops | $225 a month | September 2026 |

These prices buy a preparation with no published human absorption data, so a cheaper bottle is not necessarily better value. The sellers of drops, troches and dissolving tablets are on our [sublingual semaglutide board](https://glpwatchdog.org/best/compounded-semaglutide/sublingual). Compare every non-injected option, including tablets, on our [oral GLP-1 provider board](https://glpwatchdog.org/best/oral-glp1-providers), and see [compounded versus brand semaglutide](https://glpwatchdog.org/research/compounded-semaglutide-vs-brand-semaglutide) for the wider trade-off.

Other sellers offer compounded semaglutide by mouth in forms outside that table, and the same absorption caveat applies. [MedLeanRx](https://glpwatchdog.org/reviews/medleanrx), a [Texas](https://glpwatchdog.org/states/texas)-only service, sells a daily oral tablet, and [Rila](https://glpwatchdog.org/reviews/rila) sells a dissolvable tablet whose lowest advertised rate assumes a 6-month commitment. [He & She MD](https://glpwatchdog.org/reviews/he-and-she-md), [Rivo Health](https://glpwatchdog.org/reviews/rivo-health) and [Go Vida Plena](https://glpwatchdog.org/reviews/go-vida-plena) list oral versions of compounded semaglutide and tirzepatide without describing the form on their public pages, so ask what it is before you order. [HealthSource](https://glpwatchdog.org/reviews/healthsource) [sells compounded tirzepatide as an oral sublingual](https://glpwatchdog.org/research/tirzepatide-pills-what-is-sold), a form with no approved counterpart at all. [The Wellness Company](https://glpwatchdog.org/reviews/the-wellness-company) sells a compounded 10 mg tirzepatide tablet dissolved under the tongue once a day, at $349.99 every 30 days. [MEDVi](https://glpwatchdog.org/reviews/medvi) sells a compounded GLP-1 tablet that dissolves once a day, alongside its weekly injection. [Flo Clinic](https://glpwatchdog.org/reviews/flo-clinic), which serves New Jersey and New York, sells compounded semaglutide and tirzepatide as daily dissolving tablets, and its oral semaglutide starts at $364.99 a month against $214.99 for its starter injection, plus $35 shipping on each. [North Carolina Trim Clinic](https://glpwatchdog.org/reviews/north-carolina-trim-clinic) offers an under-the-tongue tablet beside its weekly injections, though its only published price is a $149-a-month starting figure for the injectable program.

[Lavender Sky Health](https://glpwatchdog.org/reviews/lavender-sky-health) lists sublingual semaglutide and sublingual tirzepatide plans from a compounding pharmacy, sold as fixed 60-day supplies rather than monthly refills. [Riovie](https://glpwatchdog.org/reviews/riovie) sells compounded semaglutide and tirzepatide as sublingual tablets alongside its injections, and on its one-month plan the semaglutide tablet costs $209 against $149 for the semaglutide injection. [Thrivelab](https://glpwatchdog.org/reviews/thrivelab) also charges more for the mouth form: its oral semaglutide, taken daily under the tongue, is $225 for the first month and from $300 a month after that, against $175 to $250 a month for its injections. [Rejuvenate MedSpa](https://glpwatchdog.org/reviews/rejuvenate-medspa) sells oral tirzepatide as an extended-release troche taken once a week, priced by dose up to $490 a month at 40 mg a week.

## If you want semaglutide without injections

The Wegovy tablet is the approved way to take semaglutide for weight loss without a needle. Its label carries the dosing rules above and its own trial results.[1] Our [Wegovy guide](https://glpwatchdog.org/drugs/wegovy) covers both forms, and [brand semaglutide providers](https://glpwatchdog.org/best/semaglutide-providers/brand) lists sellers who prescribe the branded drug. For type 2 diabetes, see [Rybelsus](https://glpwatchdog.org/drugs/rybelsus). Brand names can be confusing here; [brand names versus molecules](https://glpwatchdog.org/research/brand-names-vs-molecules) sorts out which product contains which drug. For another oral option, see our [Foundayo guide](https://glpwatchdog.org/research/foundayo-orforglipron-oral-glp1).

## Common questions

## Frequently asked questions

### Do sublingual semaglutide drops work?

It has not been shown. There is no FDA-approved sublingual semaglutide, and we found no published human study measuring how much semaglutide from drops reaches the blood or how much weight people lose on them. The only published sublingual studies are in animals.

### Is sublingual semaglutide the same as the Wegovy pill?

No. The Wegovy tablet is FDA-approved, is swallowed rather than held under the tongue, and contains an absorption enhancer called SNAC. Its label still puts absorption at about 1% to 2% of the dose, and it must be taken fasting with a small sip of water (4 ounces at most), followed by half an hour without food or drink. Sublingual drops are compounded preparations with no FDA review.

### How much do semaglutide drops cost?

Among the 29 sellers we track that list a drop, sublingual or lozenge form of compounded semaglutide, starting prices run from $99 to $400 a month, last checked between September 2026 and November 2026. Several charge more at higher doses or less on prepaid plans.

### Can I compare a drop dose with my injection dose?

Not reliably. The approved Wegovy tablet needs 25 mg a day to do the work of a 2.4 mg weekly injection, and the Rybelsus label says even two approved semaglutide tablets are not interchangeable milligram for milligram. A compounded drop has no published human absorption data to convert from.

### Are there any human trials of sublingual semaglutide?

We found none with published results. One registered trial, NCT07092605, includes a weekly sublingual GLP-1 arm; as of September 2026 it was enrolling by invitation and had posted no results.

## References

1. Novo Nordisk WEGOVY (semaglutide) injection and WEGOVY (semaglutide) tablets, prescribing information. DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
2. Novo Nordisk RYBELSUS (semaglutide) tablets and OZEMPIC (semaglutide) tablets, prescribing information. DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98
3. U.S. Food and Drug Administration FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA. 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
4. Liu Y, Song G, Banov D, et al. Single-dose pharmacokinetics of sublingual semaglutide in rats. Eur J Pharm Sci. 2026. PMID: 41386332. DOI: 10.1016/j.ejps.2025.107406. https://pubmed.ncbi.nlm.nih.gov/41386332/
5. Sagar G, Stránská V, Stránská D, et al. Electrospun Nanofiber Oral Thin Film Platform for Sublingual Peptide Delivery: A Promising Alternative to Conventional Semaglutide Formulations. Diabetes Obes Metab. 2026. PMID: 42297758. DOI: 10.1111/dom.71015. https://pubmed.ncbi.nlm.nih.gov/42297758/
6. Klein Cerrejon D, Krupke H, Gao D, et al. Optimized suction patch design for enhanced transbuccal macromolecular drug delivery. J Control Release. 2025. PMID: 39938719. DOI: 10.1016/j.jconrel.2025.02.014. https://pubmed.ncbi.nlm.nih.gov/39938719/
7. Luo Z, Klein Cerrejon D, Römer S, et al. Boosting systemic absorption of peptides with a bioinspired buccal-stretching patch. Sci Transl Med. 2023. PMID: 37756378. DOI: 10.1126/scitranslmed.abq1887. https://pubmed.ncbi.nlm.nih.gov/37756378/
8. Wu J, Jones N, Hohenwarter L, et al. Systemic delivery of proteins using novel peptides via the sublingual route. J Control Release. 2024. PMID: 38423473. DOI: 10.1016/j.jconrel.2024.02.042. https://pubmed.ncbi.nlm.nih.gov/38423473/
9. Belcourt J, Sapowadia A, White CM Compounded Semaglutide and Tirzepatide Products Use Unique Formulations but Efficacy and Safety Largely Unknown. Ann Pharmacother. 2026. PMID: 41689811. DOI: 10.1177/10600280261421979. https://pubmed.ncbi.nlm.nih.gov/41689811/
10. ClinicalTrials.gov NCT07092605: Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures. ClinicalTrials.gov. 2026. https://clinicaltrials.gov/study/NCT07092605

---

Cite as: GLP Watchdog, Ruth Calder, "Sublingual Semaglutide Drops: What the Evidence Shows", published 2026-09-27, updated 2026-11-02. https://glpwatchdog.org/research/sublingual-semaglutide-drops-evidence

Canonical HTML page: https://glpwatchdog.org/research/sublingual-semaglutide-drops-evidence

Medical disclaimer: Nothing here is medical advice. We report on this subject; we do not treat anyone. Whether to begin a medication, supplement, or treatment, whether to adjust it, and whether to stop are questions for a clinician licensed to answer them, who knows your history.